<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01901640</url>
  </required_header>
  <id_info>
    <org_study_id>DA8159_EDDL_III</org_study_id>
    <nct_id>NCT01901640</nct_id>
  </id_info>
  <brief_title>Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction</brief_title>
  <official_title>Phase 3 Study to Evaluate Longterm Safety of Once-a-Day Dosing of Udenafil in the Treatment of Erectile Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dong-A Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dong-A ST Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase : Phase III Indication : Erectile Dysfunction Study Design : open-label, fixed dose,
      6-month extension study (parent study : DA8159_EDD_III)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Completer from parent study(DA8159_EDD_III)continued into a 24weeks open-label extension
      during which they received udenafil once daily. The study concluded with a 4-week ED
      treatment-free period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>48 weeks(after 24 weeks of parent study), 52weeks(after 28weeks of parent study)</time_frame>
    <description>Safety evaluation included adverse events, standard 12-lead electrocardiograms and clinical laboratory measures. The AEs measured as percentage and number of patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>International Index of Erectile Function(IIEF), GAQ(Global Assessment Questions), Shift to normal</measure>
    <time_frame>48 weeks(after 24 weeks of parent study), 52weeks(after 28weeks of parent study)</time_frame>
    <description>The efficacy measures(Unit of Measure)
IIEF EF domain score(Change from baseline)
IIEF other domain scores(Change from baseline)
GAQ &amp; Shift to normal(percentage of subject)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">302</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>DA-8159</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Udenafil(The study had one arm.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DA-8159 (Udenafil)</intervention_name>
    <arm_group_label>DA-8159</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patients aged 20 years or more diagnosed with erectile dysfunction(ED)

        Exclusion Criteria:

          -  Had uncontrolled blood pressure

          -  Had hepatic or renal dysfunction

          -  Had significant psychiatric disorders or drug abuses

          -  Was currently under anticancer chemotherapy

          -  Had a treatments for ED using other phosphodiesterase type 5(PDE-5) inhibitors
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>S W Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>the Catholic University of Korea St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>D G Moon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J J Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Anam Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>N C Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>S W Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J S Paick, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>T Y Ahn, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>K H Moon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yeungnam University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>W S Chung, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ewha Womans University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>K S Min, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J K Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonbuk National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>D Y Yang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangdong Sacred Heart Hospital</affiliation>
  </overall_official>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2013</study_first_submitted>
  <study_first_submitted_qc>July 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2013</study_first_posted>
  <last_update_submitted>July 15, 2013</last_update_submitted>
  <last_update_submitted_qc>July 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Udenafil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

